Hologic, Inc. (NASDAQ:HOLX) has a 1 Year Target Estimate of $43.33. The stock traded with the volume of 2.9 Million in the last trading session. Hologic, Inc. opened at $38.85 and closed by showing an increase of 0.78%. The Bid price in the last session was $38.69 x 100 and the Ask price was $41.50 x 100. (The ask price is what sellers are willing to take for it. If you are selling a stock, you are going to get the bid price, if you are buying a stock you are going to get the ask price. The difference (or spread) goes to the broker/specialist that handles the transaction).
Hologic, Inc. has the Market Capitalization of 10.84 Billion. The Stock has its 52-week High of $41.66 and 52-Week Low of $31.84 and it touched its 52-week high on Dec 2, 2015 and 52-Week Low on Feb 12, 2016.
Hologic, Inc. reported its last Earnings on Nov 02 AMC where the company reported Actual EPS of $0.52/Share whereas, the Analyst Estimated EPS was $0.5/share. The difference between Actual EPS and Estimated EPS was $0.02/share. This represented an Earnings Surprise of 4%. The company will report its next earnings on Jan 25 – Jan 30 (Est.).
Some analyst provided their insight on Growth Estimates; Hologic, Inc. has the Current Quarter Earnings Growth rate of 10.9%. The Next Quarter growth is expected to be 10.6%. In the past 5 years, the stock has earnings growth rate of 7.66% per annum while the Upcoming 5 year’s earnings growth rate is expected to be 9.73% per annum.
15 number of analysts also provided their insight on Hologic, Inc., where the Average Price Target for the stock is $43.33. They also projected Low Price Target as $39 while High Price Target is set at $48.
A number of analysts rated the stock as well: 8 analysts believe that the stock is a STRONG BUY while 6 reported it as Buy.7 analysts assigned a HOLD rating, 0 said it’s UNDERPERFORM and 0 say that this stock is a SELL.
Hologic, Inc. annual Divided is 0 while it’s Dividend Yield is 0%. The stock has its Price to Earnings (P/E) ratio of 33.69 and Forward Price to Earnings ratio of 16.52. The company has its Price to Sales (P/S) ratio of 3.83 where Price to Book (P/B) ratio of 5.05, Price to Cash Per share (P/C) of 19.78 and Price to Free Cash Flow (P/FCF) has a value of 15.75.
The company has its Return on Assets (ROA) of 4.5 Percent. Return on Equity (ROE) stands at 15.8% and Return on Investment (ROI) displays a value of 8.4%.
The stock is currently trading at Distance from 20-Day simple moving Average of 3.45% whereas, Distance from 50-Day Simple moving average is 2.28 Percent and Distance from 200-Day Simple Moving Average of 7.33 percent.
A look at performance overview of Hologic, Inc. depicts that Performance (Week) is 0.85 percent while Performance Month is 8.34%. Quarterly performance shows a value of 1.35% and Half Year Performance value stands at 12.46%. Yearly performance of the stock has the value of -3.4 percent. Hologic, Inc. has its YTD performance of 0.75 Percent. (YTD performance is the most important factor to consider; if YTD is negative, the stock is declining; if the YTD Performance value is Positive the stock is surging).
Many Insiders have done trades inside the company. The latest trade was made on 14 Nov 2016 where Officer Oberton Karleen Marie did a transaction type “Sell” in which 1211 shares were traded at a price of $36.55. Another insider trade includes Officer Oberton Karleen Marie who also initiated a transaction in which 1794 shares were traded on 13 Nov 2016 as “Buy”. On 13 Nov 2016 Officer Oberton Karleen Marie traded 583 shares as “Sell” at $36.45. Chief Financial Officer Mcmahon Robert W Sell 1161 shares on 6 Nov 2016 at the price of $38.68.
The latest Upgrades/Downgrades was done by Research firm Barclays on 23-Sep-16 who Upgrade the stock from Equal Weight to Overweight. Other firms have also Upgraded/Downgraded the stock. On 28-Apr-16, Needham took an action “Downgrade” from Buy to Hold. On 28-Jan-16, the stock was Upgrade to Buy by Needham.